R-Tech Ueno has been planning the marketing and promotion of Rescula® Eye Drops with Santen Pharmaceutical Corporation. We also make aggressive efforts in disseminating information by our own Medical Representatives.
Dissemination of Information on New Findings
Taking advantages of being the discoverer and developer of Rescula® Eye Drops, we communicate the latest scientific information on Rescula®, contributing to appropriate Glaucoma treatments that depend on new evidence.
Planning and Hosting Lecture Conferences
In cooperation with Santen Pharmaceutical, we have been planning and hosting lecture conferences directed at ophthalmologists and paramedical staff in order to introduce brand new medical information to a wider audience of doctors.
Active Participation in the Ophthalmic Meetings
We are active participants in the ophthalmic community (Japanese Ophthalmic Association, Japanese Clinical Ophthalmic Association, Japan Glaucoma Association, etc.); with whom we organize seminars based on the expertise of highly recognized doctors, and disseminate news of the latest professional observations in the medical field. For example, the seminar series entitled "Unraveling the Mysteries of Rescula®" garnered huge acclaim.
Advancing Basic Research
We advance basic research on the pharmacological mechanisms of Rescula® Eye drops. All discoveries are then announced to the clinical field by way of presentations at medical meetings and academic papers.
